Francisco Vicente-García

<i>CHL1</i> hypermethylation as a potential biomarker of poor prognosis in breast cancer

Esperanza Martín‐Sánchez, Saioa Mendaza, Ane Ulazia-Garmendia et al. · Oncotarget · 2017 · 34 citations · Full text

Medicine, Oncology, Pathology +17

Differential involvement of<i>RASSF2</i>hypermethylation in breast cancer subtypes and their prognosis

Noemí Pérez‐Janices, Idoia Blanco‐Luquin, Natalia Torrea et al. · Oncotarget · 2015 · 30 citations · Full text

Life Sciences, Genetics, Oncology +17

CDH22 hypermethylation is an independent prognostic biomarker in breast cancer

Esperanza Martín‐Sánchez, Saioa Mendaza, Ane Ulazia-Garmendia et al. · Clinical Epigenetics · 2017 · 17 citations · Full text

Medicine, Molecular Biology, Oncology +17

Gene promoter hypermethylation is found in sentinel lymph nodes of breast cancer patients, in samples identified as positive by one-step nucleic acid amplification of cytokeratin 19 mRNA

Esperanza Martín‐Sánchez, E. Pernaut-Leza, Saioa Mendaza et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2016 · 14 citations

Medicine, Molecular Biology, Oncology +15

Selective sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer: results of the GEICAM 2005-07 study

Antonio Piñero, María J. Escudero-Barea, Francisco Fernández-Robayna et al. · Cirugía Española (English Edition) · 2014 · 12 citations

Medicine, Oncology, Breast Oncology +16